Annotation. Medicinal plant St. John's wort (Hypericum perforatum L) is widely used in medicine in many countries of the world as a natural antidepressant, and due to its antitumor and cytotoxic effects. Research is being actively conducted on the use of St. John's wort in other areas of medicine. The purpose of the study is a marketing analysis of medicinal products that are registered in Ukraine with the active ingredient St. John's wort (Hypericum perforatum L.). The research material was data from the State Register of Medicinal Products of Ukraine in 2022, declared wholesale and retail prices in Ukraine as of October 2022. The research methods were frequency and content analysis. According to the ATS classification of medicinal products with the active ingredient St. John's wort on the pharmaceutical market of Ukraine, the presence of 4 groups has been established: A - agents affecting the digestive system and metabolism, N - agents affecting the nervous system, L - antineoplastic and immunomodulating agents, G-agents affecting the genitourinary system and sex hormones. According to the declared wholesale and retail prices as of October 2022, various forms of release of medicines were established, namely tablets, capsules, collections, solutions, herbs, drops, tinctures, syrups and balms. The cost of various dosage forms with the active ingredient St. John's wort was determined. It was established that the cost of 1 package ranges from UAH 10.57 to UAH 474.21. As a result of the content analysis, an assortment of medicinal forms registered on the territory of Ukraine and consisting of 27 trade names was established. The medical fees are presented by 5 TN and occupy 18.52% of the pharmaceutical market of Ukraine. According to the ATS classification, the largest group of drugs with the active ingredient St. John's wort is group A – drugs that affect the digestive system and metabolism. During the analysis of manufacturers of modern dosage forms it was established that the ratio of domestic and foreign production is 3:1, where domestic dosage forms make up 74%. In the future, it is planned to carry out a more detailed content analysis of drugs, taking into account accessibility for the consumer/patient and the development of new complex drugs that based on St. John's wort.
Acute respiratory viral infections (ARI) and influenza occupy a leading place in the structure of the overall morbidity of the population in most countries. Aim. To assess the rational prescription of drugs for etiotropic therapy of ARI in the outpatient practice. Materials and methods. The following materials for research were used: case histories; treatment sheets; the Unified clinical protocol of primary care for adults and children “Acute respiratory infections”; data of the State Formulary of Medicines as of January 2021; the Register of wholesale prices; the weekly “Apteka” (Pharmacy). The methods of retrospective, descriptive, frequency, and VEN-analysis were applied. Results. According to the research results, using patient histories, it was found that family doctors prescribed 67 drugs by trade names. For etiotropic therapy, 24 drugs were used; it was 37 % of the total number, and 63 % – for symptomatic therapy. Such drugs as Amizon, Aflubin, Amixin, Resistol, Umkalor were for etiotropic therapy (more than 5 prescriptions). None of these drugs is included in the State Formulary of Medicines and the Unified clinical protocol for the treatment of influenza and SARS. Thus, these drugs are without the proven efficiency, safety and cost-effective use. Conclusions. The study conducted has shown that the drugs prescribed most often do not have an evidence base of efficacy and safety; none of the most frequently prescribed drugs is included in the State Formulary of Medicines and the Unified clinical protocol. A direct relationship between an increase in the number of prescriptions and an increase in price has been proven. Key words: acute respiratory viral infections; influenza; frequency analysis; VEN-analysis; family doctor.
In modern working conditions, a pharmacist has insufficient knowledge of regulatory documents regulating the activities of the pharmaceutical industry. Thus, there is a need to provide informational assistance to the pharmacist by systematizing the current legal documents. Aim. To scientifically generalize legal acts on the state regulation of the business entity in pharmacy in Ukraine. Materials and methods. Regulatory legal acts regulating the process of the state regulation of the activity of an economic entity in pharmacy in Ukraine, and such methods as content analysis, generalization were used. Results. As a result of the content-analysis it has been found that state supervision (control) of the pharmaceutical market of Ukraine is performed by the following state structures: the State Service of Ukraine for Medicines (Drugs) and Drug Control, the State Service of Ukraine for Food Safety and Consumer Protection, the State Fiscal Service, the State Labor Service of Ukraine, the State Emergencies Service of Ukraine. Conclusions. When conducting the content-analysis it has been found that the legal documents regulating the process of pharmaceutical care provision in Ukraine are the Laws of Ukraine “On licensing of the economic activities”, “On consumer protection”, “On labor protection”. A graphic model of the state regulation of the business entity’s activity in Ukraine has been also created. Key words: state regulation; business entity in pharmacy; regulatory legal acts; content-analysis.
Influenza and other acute respiratory viral infections (ARIs) are the most common among human diseases that require timely medical attention and treatment with the most effective drugs. The aim of the study is pharmacoepidemiological analysis of drugs for the treatment of influenza registered in Ukraine. Materials and methods of research. The study was based on data from the State Register of Medicines of Ukraine, information on the results of the epidemic season of influenza and acute respiratory infections of the Center for Public Health of the Ministry of Health of Ukraine, declared drugs under the International Nonproprietary or Common Name in Ukraine as of January 2021. Methods: retrospective, descriptive and frequency analyzes. Results and discussion. A pharmacoepidemiological analysis of influenza drugs in Ukraine was conducted. It was found that the incidence of influenza and SARS during the study period decreased by 3.1% of the total population. Fatalities due to influenza and SARS increased by 41 cases during the study period, which may be related to the coronavirus pandemic. According to the results of a marketing study of antiviral drugs, it was found that the largest share in the structure of registered trade names are interferons (11 trade names). Conclusions. The analysis of the market showed that among the antiviral drugs registered in Ukraine for the studied period the dominance of domestic drugs is noted - 54% (respectively of foreign origin - 46%). Analysis of the distribution of domestic analogues of antiviral drugs by manufacturers found that the largest (5 and 4 TN) belongs to LLC "Research and production company" Interpharmbiotek and FZ "Biopharma" Ltd., Ukraine, Bila Tserkva. Key words: influenza; pharmacoepidemiological analysis; antiviral drugs
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.